Schizophrenia/Psychosis

What is the impact of antipsychotic side effects on medication adherence?

Individuals with a psychotic disorder are 2.5 times more likely than those without one to develop dementia.

Herbal medicines have been used to treat mental health disorders since ancient times, and continue to be useful today.

What is the effect of cannabis use on adherence to medications in patients with psychosis?

From ketamine response to differences between mTBI and concussion, here are highlights from the week in Psychiatric Times.

Will it hurt my baby? Researchers investigated associations between first trimester exposure to second-generation antipsychotics and major congenital malformations.

The FDA has accepted the NDA for aripiprazole 2-month, ready-to-use, long-acting injectable.

Long-acting injectable haloperidol decanoate may work as a treatment for Adderall-induced persistent psychosis.

A recent study demonstrates how large-scale, real-world data analyses can elucidate patterns of disease comorbidity.

Getting the “NAC” of treating negative symptoms: Researchers performed a randomized controlled trial of N-acetylcysteine in clozapine-resistant schizophrenia.

Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.

This novel schizophrenia treatment showed positive results in a phase 3 trial evaluating efficacy, safety, and tolerability.

The experts weighed in on a wide variety of psychiatric issues for the July 2022 issue of Psychiatric Times.

Exploring the association between methamphetamine use and the development of psychotic symptoms, such as paranoid delusions, ideas of reference, and auditory hallucinations.

It is time for gender-sensitive first-episode psychosis services.

Researchers performed a nationwide register-based study of primary antipsychotic nonadherence in schizophrenia.

The experts weighed in on a wide variety of psychiatric issues for the June 2022 issue of Psychiatric Times.

All mental health clinicians must now develop skills in cultural competence to avoid perpetuating disparities in health outcomes for BIPOC individuals with serious mental illnesses.

Over the past 6 months, Psychiatric Times has featured expert opinions on important psychiatric issues from psychosis to psychedelics.

Does the “early bird get the worm”? Researchers investigated long-term outcomes with an early-switch long-acting injectable antipsychotic in patients with schizophrenia using a population-based cohort.

Interim study results show 77% treatment response rate among participants.

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.

Sociocultural factors have been shown to impact both the presentation and course of schizophrenia/psychosis. Learn more here.

Researchers investigated population-level phenotypes occurring before and after diagnosis of schizophrenia using a large health insurance claims dataset.

In this Special Report, clearly delineate the clinical context of selective psychoses.